TrialCancer discovery2016

Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia.

Marina Konopleva et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.